Michael Kresken
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antibiotic Resistance in Bacteria 35
- Pharmacology 34
- Antibiotics Pharmacokinetics and Efficacy 32
- Co-authors
- B. Wiedemann (10 shared papers)D. Häfner (14 shared papers)Harald Seifert (16 shared papers)Barbara Körber-Irrgang (16 shared papers)Wolfgang Witte (3 shared papers)Christa Cuny (2 shared papers)Paul G. Higgins (5 shared papers)Ralf René Reinert (4 shared papers)
- Journals
- International Journal of Antimicrobial Agents (10 papers)Journal of Antimicrobial Chemotherapy (6 papers)European Journal of Clinical Microbiology & Infectious Diseases (6 papers)Antibiotics (5 papers)Clinical Microbiology and Infection (5 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Michael Kresken
71 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 90
- Molecular Medicine 621
- Applied Microbiology and Biotechnology 146
- Clinical Biochemistry 238
- Endocrinology 142
- Infectious Diseases 406
Countries citing papers authored by Michael Kresken
This map shows the geographic impact of Michael Kresken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kresken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kresken more than expected).
Fields of papers citing papers by Michael Kresken
This network shows the impact of papers produced by Michael Kresken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kresken. The network helps show where Michael Kresken may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kresken, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 99 | |
| 2 | 1988 | 87 | |
| 3 | 2012 | 68 | |
| 4 | 2020 | 67 | |
| 5 | 2011 | 64 | |
| 6 | 1994 | 56 | |
| 7 | 1995 | 56 | |
| 8 | 2004 | 55 | |
| 9 | 2000 | 52 | |
| 10 | 2013 | 48 | |
| 11 | 1989 | 48 | |
| 12 | 2015 | 45 | |
| 13 | 2005 | 36 | |
| 14 | 2001 | 32 | |
| 15 | 2014 | 32 | |
| 16 | 2020 | 29 | |
| 17 | 2017 | 26 | |
| 18 | 2011 | 24 | |
| 19 | 2020 | 23 | |
| 20 | 2005 | 22 |
About Michael Kresken
Michael Kresken is a scholar working on Molecular Medicine, Pharmacology, Infectious Diseases, Epidemiology and Clinical Biochemistry, having authored 73 papers that have together received 1.4k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (35 papers), Antibiotics Pharmacokinetics and Efficacy (32 papers), Antimicrobial Resistance in Staphylococcus (26 papers), Bacterial Identification and Susceptibility Testing (18 papers), Urinary Tract Infections Management (10 papers), Pneumonia and Respiratory Infections (8 papers), Antibiotic Use and Resistance (8 papers) and Bacterial biofilms and quorum sensing (5 papers). The work is most often cited by research in Molecular Medicine (621 citations), Applied Microbiology and Biotechnology (146 citations), Clinical Biochemistry (238 citations), Endocrinology (142 citations) and Infectious Diseases (406 citations). Michael Kresken has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include B. Wiedemann, D. Häfner, Harald Seifert, Barbara Körber-Irrgang, Wolfgang Witte, Christa Cuny, Paul G. Higgins, Ralf René Reinert, Thomas A. Wichelhaus and Christof von Eiff. Their work appears in journals such as International Journal of Antimicrobial Agents, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases, Antibiotics and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.